Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Howard Marks, latest 13F

Salix Pharmaceuticals

In Howard Marks's portfolio · Oaktree Capital Management

Ticker SLXP.CV

Not in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q1 2014 Sell 0  
Q4 2013 Reduce 59% 36,808,000 1.0% $54.6M
Q3 2013 Reduce 21% 89,905,000 2.1% $110.6M
Q2 2013 Buy 113,465,000 2.8% $136.1M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.